Anemia News and Research

RSS

Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.

Heparinase I is not a suitable replacement for protamine

The results of an international clinical trial led by Duke University Medical Center researchers has shown that a new drug is not a suitable replacement for protamine, a drug that has been used for more than 40 years after coronary artery bypass surgery to return thinned blood to its normal state.

1 Aug 2005

Combination antiretroviral drug therapy may reduce the risk of mother-to-child HIV transmission

Two new studies support the hypothesis that combination antiretroviral drug therapy may reduce the risk of mother-to-child HIV transmission through breastfeeding, findings that could have significant implications in the developing world.

29 Jul 2005

New chemical compound can accelerate stem cell mobilization

The finding has led to the development of a new chemical compound that can accelerate this process (called stem cell mobilization) in mice - which could eventually lead to more efficient stem cell harvesting for human use.

26 Jul 2005

Mixture of 8 bacteria (VSL#3) for 6 weeks helps ulcerative colitis

A mixture of bacteria developed in part by University of Alberta researchers has been proven highly effective in treating people suffering from ulcerative colitis.

25 Jul 2005

Reliable research about the benefits and harms of treatments for malaria in pregnant women is scarce

Few studies compare the effects of different drug regimes in pregnant women, and many of the best studies were conducted in Southeast Asia, where malaria transmission rates are low, says researcher Lois Orton of the University of York in England.

20 Jul 2005

Combination of ribavirin and interferon is more effective in treating hepatitis C than using interferon alone

The researchers reviewed 72 randomized trials and 9,991 patients who had chronic hepatitis C for more than six months and were previously untreated, who had relapsed after treatment or who had not responded to other treatment.

19 Jul 2005

Chemical sealant - poloxamer 188 can repair damage to cardiac muscle cell membrane

A common chemical used in the manufacturing and pharmaceutical industries can repair damage to cardiac muscle cell membranes and prevent heart failure in mice with the genetic mutation that causes Duchenne muscular dystrophy, according to scientists at the University of Michigan Medical School.

18 Jul 2005

New molecular insights may one day lead to opportunities to stave off old age

Delving deep into the molecular subtleties of a strain of mice engineered to age rapidly, scientists have found that an accumulation of genetic mutations prompts a cascade of programmed cell death that seems to underpin the aging process.

18 Jul 2005

Research discovers new deadly link to sickle cell disease

A new study led by a researcher at Children's Hospital & Research Center at Oakland is the first to find that an amino acid deficiency in sickle cell disease is the result of hemolysis, a process where red blood cells rupture and release their contents into the blood stream. Low availability of the amino acid arginine is associated with lung disease and death in adult sickle cell patients.

6 Jul 2005

Ten million Africans treated by international disease treatment

A disease treatment programme started three years ago by Imperial College London has now treated over ten million African children and adults for schistosomiasis and intestinal worm infections in six sub-Saharan countries.

6 Jul 2005

Scientists discover identifying markers for primitive blood-forming stem cells - simplifies cell identification

Scientists at the University of Michigan Medical School have discovered the biological equivalent of a grocery store bar code on the surface of primitive, blood-forming stem cells in mice. Called hematopoietic stem cells, they give rise to all the different types of specialized cells found in blood.

30 Jun 2005

Medical experts say that yearly checkup not necessary - doctors and patients disagree

Though you and your doctor might think that yearly checkup is just a routine part of staying healthy, that practice isn't endorsed by a panel of experts.

29 Jun 2005

New UK Guidance to be issued on Hepatitis C as 'silent epidemic'

Leading medical experts from throughout the UK will be gathering in Edinburgh today and tomorrow (21-22 April 2004) to arrive at a consensus on how best to treat and manage the 'silent epidemic' of hepatitis C - a virus which is estimated to be carried by over 400,000 people in the UK and which continues to spread globally, as the majority of carriers do not realise they have been infected.

21 Jun 2005

Inexpensive tests can be used to decide who needs HIV treatment in poor countries

Researchers from the Johns Hopkins Bloomberg School of Public Health, Centers for Disease Control and Prevention and the Chiang Mai University in Thailand, evaluated the ability of inexpensive biological markers, which are obtainable in resource-poor countries, to determine which HIV-infected patients are in the greatest need of antiretroviral therapy.

20 Jun 2005

Immune system discovery could help in the treatment of bowel cancer

Scientists investigating whipworms, parasites that infect one-fifth of the world's population as well as livestock and domestic animals, have discovered a new way that the body effectively eliminates the parasites.

From The University of Manchester 16 Jun 2005

Hydroxyurea may prevent complications such as organ damage and stunted growth in treatment of sickle cell disease

Treating babies who have sickle cell disease (SCD) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital.

16 Jun 2005

Anemia News and Research

Further Reading

Heparinase I is not a suitable replacement for protamine

Combination antiretroviral drug therapy may reduce the risk of mother-to-child HIV transmission

New chemical compound can accelerate stem cell mobilization

Mixture of 8 bacteria (VSL#3) for 6 weeks helps ulcerative colitis

Reliable research about the benefits and harms of treatments for malaria in pregnant women is scarce

Combination of ribavirin and interferon is more effective in treating hepatitis C than using interferon alone

Chemical sealant - poloxamer 188 can repair damage to cardiac muscle cell membrane

New molecular insights may one day lead to opportunities to stave off old age

Research discovers new deadly link to sickle cell disease

Ten million Africans treated by international disease treatment

Scientists discover identifying markers for primitive blood-forming stem cells - simplifies cell identification

Medical experts say that yearly checkup not necessary - doctors and patients disagree

New UK Guidance to be issued on Hepatitis C as 'silent epidemic'

Inexpensive tests can be used to decide who needs HIV treatment in poor countries

Immune system discovery could help in the treatment of bowel cancer

Hydroxyurea may prevent complications such as organ damage and stunted growth in treatment of sickle cell disease

Oral liquid Hydroxyurea promising for long-term use in babies with sickle cell disease

New Zealand moves to routinely offering antenatal HIV screening

Chemo combo increases breast cancer survival

Blood abnormality, sickle cell trait, gives added protection to children from malaria

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News